MariTide looking worse and worse with every single data release....


anonymous

Guest
...can we develop and launch anything? Or has our culture of sell your individual story up as our Prime Directive finally caught up across the company? Today's results were underwhelming to say the least.


Looks like it time to buy a successful launch from a nimble performance based company and kill their culture while we fool Wall Street one more time.
 


...can we develop and launch anything? Or has our culture of sell your individual story up as our Prime Directive finally caught up across the company? Today's results were underwhelming to say the least.


Looks like it time to buy a successful launch from a nimble performance based company and kill their culture while we fool Wall Street one more time.
Didn’t we just do that with Horizon? Because we sure as hell killed their culture.
 


Let’s give this drug to the cardiovascular division - they can really screw it up and make the sales reps even more miserable- they will story tell, quantify, and call on the M targets that have lower potential and only count a select amount of scripts. Give this to us - primary care.
 


No, give it to the Dynasty. We allow ZS to tell us who's important instead of what we know in offices and call MOHS surgeons A targets and call on them 16x a quarter. We ignore others who actually treat PSO, but we hit hard with HIQs and close like vice.
 


No, give it to the Dynasty. We allow ZS to tell us who's important instead of what we know in offices and call MOHS surgeons A targets and call on them 16x a quarter. We ignore others who actually treat PSO, but we hit hard with HIQs and close like vice.
No, give it to HQ to sell. All they do is send out Chat GPT assignments and memos. Hate to tell ya, Chat GPT ain't going to get drugs approved. Maybe employees can use this tool to save time during the workday posting and reacting on LinkedIn.
 











Write your reply...